Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan T Oronsky

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Translational Oncology|August 2, 2011
Six degrees of separation: the oxygen effect in the development of radiosensitizersBryan T Oronsky, Susan J Knox, Jan Scicinski
Translational Oncology|April 13, 2012
Is Nitric Oxide (NO) the Last Word in Radiosensitization? A ReviewBryan T Oronsky, Susan J Knox, Jan J Scicinski
Translational Oncology|June 29, 2012
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a reviewBryan T Oronsky, Jan J Scicinski, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Case Reports in Oncology|November 25, 2015
Dysphonia after Bevacizumab Rechallenge: A Case ReportCorey A Carter, Scott Z Caroen, Arnold L Oronsky, et al.
Case Reports in Oncology|May 31, 2016
Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome?Corey A Carter, Jan J Scicinski, Harry E Lybeck, et al.
Case Reports in Oncology|March 3, 2016
The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced PneumonitisCorey A Carter, Robert Browning, Bryan T Oronsky, et al.
Medical Oncology (Northwood, London, England)|May 1, 2016
"No patient left behind": an alternative to "the War on Cancer" metaphorBryan T Oronsky, Corey A Carter, Arnold L Oronsky, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 8, 2014
Follow the ATP: tumor energy production: a perspectiveBryan T Oronsky, Neil Oronsky, Gary R Fanger, et al.
Case Reports in Oncology|March 3, 2016
RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case ReportChristina Brzezniak, Bruno A Schmitz, Paul G Peterson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Translational Oncology|August 2, 2011
Six degrees of separation: the oxygen effect in the development of radiosensitizersBryan T Oronsky, Susan J Knox, Jan Scicinski
Translational Oncology|April 13, 2012
Is Nitric Oxide (NO) the Last Word in Radiosensitization? A ReviewBryan T Oronsky, Susan J Knox, Jan J Scicinski
Translational Oncology|June 29, 2012
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a reviewBryan T Oronsky, Jan J Scicinski, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Case Reports in Oncology|November 25, 2015
Dysphonia after Bevacizumab Rechallenge: A Case ReportCorey A Carter, Scott Z Caroen, Arnold L Oronsky, et al.
Case Reports in Oncology|May 31, 2016
Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome?Corey A Carter, Jan J Scicinski, Harry E Lybeck, et al.
Case Reports in Oncology|March 3, 2016
The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced PneumonitisCorey A Carter, Robert Browning, Bryan T Oronsky, et al.
Medical Oncology (Northwood, London, England)|May 1, 2016
"No patient left behind": an alternative to "the War on Cancer" metaphorBryan T Oronsky, Corey A Carter, Arnold L Oronsky, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 8, 2014
Follow the ATP: tumor energy production: a perspectiveBryan T Oronsky, Neil Oronsky, Gary R Fanger, et al.
Case Reports in Oncology|March 3, 2016
RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case ReportChristina Brzezniak, Bruno A Schmitz, Paul G Peterson, et al.
Pageof 2